Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Until now, cancer is still associated with high morbidity and mortality, and is therefore a big issue for the public health. Colorectal cancer is the second leading cause of cancer death in developed countries. In advanced colorectal cancer, 60% of these patients develop cachexia. The presence of cachexia plays an important role in the high mortality rate of cancer. Cachexia is characterized by involuntary weight loss with loss of skeletal muscle with or without loss of fat mass. The aim of this study is to determine the feasibility of taking muscle biopsies of cachectic colorectal cancer patients. Skeletal muscle characteristics will be compared between biopsies of the m. erector spinae and the m. vastus lateralis from cachectic colorectal cancer patients, non-cachectic colorectal cancer patients and healthy controls. 10 cachectic, 25 non-cachectic, and 25 healthy controls will be recruited for this study. It is an observational study, so measurements will be taken at one time point. Interventions/measurements: * muscle biopsies * blood samples * 3D freehand ultrasound * Short physical performance battery test * handgrip strength * questionnaires (activity pattern, quality of life)

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• minimum age of 18 years old

• unwanted weight loss \> 5% in the last 6 months OR \> 2% unwanted weight loss in combination with a BMI \< 20kg/m2 OR \>2% unwanted weight loss in combination with sarcopenia

• Cachexia staging score (CSS): 5-12

• minimum age of 18 years old

• No unwanted weight loss \> 5% in the last 6 months OR \> 2% unwanted weight loss in combination with a BMI \< 20kg/m2 OR \>2% unwanted weight loss in combination with sarcopenia

• Cachexia staging score (CSS): 0-2

⁃ \- minimum age of 18 years old

Locations
Other Locations
Belgium
Hasselt University - REVAL research institution
RECRUITING
Diepenbeek
Jessa Hospital
RECRUITING
Hasselt
Contact Information
Primary
Britt van de Haterd, PhD student
britt.vandehaterd@uhasselt.be
0032479871509
Backup
Kenneth Verboven, Professor
kenneth.verboven@uhasselt.be
Time Frame
Start Date: 2022-01-23
Estimated Completion Date: 2025-09-10
Participants
Target number of participants: 60
Treatments
Cachectic colorectal cancer patients
Non-cachectic colorectal cancer patients
Healthy controls
Related Therapeutic Areas
Sponsors
Leads: Hasselt University

This content was sourced from clinicaltrials.gov